Joel Block to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications Joel Block has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
0.015
-
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis. 2004 Aug 01; 39(3):295-9.
Score: 0.015
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.